Background: In patients with idiopathic pulmonary fibrosis (IPF) with isolated exertional desaturation, there are limited data regarding the effectiveness of oxygen supplementation during exercise training; the underlying mechanisms that contribute to these responses are unknown. Objectives: To examine in these IPF patients the effects of oxygen supplementation during submaximal exercise (vs. medical air) on cerebral/skeletal muscle oxygenation and systemic hemodynamics. Methods: In this randomized, cross-over, placebo-controlled trial, IPF patients (n = 13; 63.4 ± 9.6 years) without resting hypoxemia but a significant desaturation during maximal cardiopulmonary exercise testing underwent 2 steady-state exercise trials (65% peak-work-load), breathing either oxygen-enriched or medical air. Cerebral/skeletal muscle oxygenation (near-infrared spectroscopy) and beat-by-beat hemodynamics (photoplethysmography) were monitored. Results: In the air protocol, from the initial minutes of submaximal exercise, patients exhibited a marked decline in cerebral oxygenated hemoglobin (O2Hb) and an abrupt rise in deoxygenated hemoglobin (HHb). Oxygen supplementation alleviated desaturation, lessened dyspnea, and prolonged exercise duration (p < 0.01). Oxygen supplementation during exercise (i) attenuated cerebral deoxygenation (cerebral-HHb: 0.7 ± 1.9 vs. 2.5 ± 1.5 μmol/L, O2 and air protocol; p = 0.009) and prevented cerebral-Hbdifference decline (2.1 ± 2.7 vs. −1.7 ± 2.0 μmol/L; p = 0.001), (ii) lessened the decline in muscle O2-saturation index, and (iii) at isotime exercise, it resulted in lower muscle-HHb (p = 0.05) and less leg fatigue (p < 0.05). No differences between protocols were observed in exercise cardiac output and vascular resistance. Conclusions: IPF patients with isolated exertional hypoxemia exhibit an inability to increase/maintain cerebral oxygenation during submaximal exercise. Correcting desaturation with O2 supplementation prevented the decline in brain oxygenation, improved muscle oxygenation, and lessened dyspnea, suggesting an efficacy of acute oxygen supplementation during exercise training in protecting brain hypoxia in these IPF patients.

1.
Raghu
G
,
Collard
HR
,
Egan
JJ
,
Martinez
FJ
,
Behr
J
,
Brown
KK
, et al.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
.
Am J Respir Crit Care Med
.
2011
;
183
(
6
):
788
824
. .
2.
Mora
AL
,
Rojas
M
,
Pardo
A
,
Selman
M
.
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
.
Nat Rev Drug Discov
.
2017
;
16
(
11
):
755
72
. .
3.
Troy
LK
,
Young
IH
,
Lau
EM
,
Corte
TJ
.
Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia
.
Respirology
.
2016
;
21
(
6
):
1005
14
. .
4.
Bonini
M
,
Fiorenzano
G
.
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
.
Eur Respir Rev
.
2017
;
26
(
143
):
1
11
. .
5.
Wickerson
L
,
Mathur
S
,
Brooks
D
,
Bonetti
LV
,
Singer
LG
,
Granton
J
, et al.
Skeletal muscle oxygenation and regional blood volume during incremental limb loading in interstitial lung disease
.
ERJ Open Res
.
2020
;
6
(
1
):
00083
2019
. .
6.
Mcnarry
MA
,
Harrison
NK
,
Withers
T
,
Chinnappa
N
,
Lewis
MJ
.
Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patients with emphysema and idiopathic pulmonary fibrosis
.
BMC Pulm Med
.
2017
;
17
(
1
):
26
10
. .
7.
Rasmussen
P
,
Nielsen
J
,
Overgaard
M
,
Krogh-Madsen
R
,
Gjedde
A
,
Secher
NH
, et al.
Reduced muscle activation during exercise related to brain oxygenation and metabolism in humans
.
J Physiol
.
2010
;
588
(
Pt 11
):
1985
95
. .
8.
Secher
NH
,
Seifert
T
,
Van Lieshout
JJ
.
Cerebral blood flow and metabolism during exercise: implications for fatigue
.
J Appl Physiol
.
2008
;
104
(
1
):
306
14
. .
9.
Søgaard
K
,
Gandevia
SC
,
Todd
G
,
Petersen
NT
,
Taylor
JL
.
The effect of sustained low-intensity contractions on supraspinal fatigue in human elbow flexor muscles
.
J Physiol
.
2006
;
573
(
Pt 2
):
511
23
. .
10.
Mahler
DA
,
Selecky
PA
,
Harrod
CG
.
Management of dyspnea in patients with advanced lung or heart disease: practical guidance from the American College of Chest Physicians consensus statement
.
Pol Arch Med Wewn
.
2010
;
120
(
5
):
160
6
. .
11.
Snider
GL
.
Enhancement of exercise performance in COPD patients by hyperoxia: a call for research
.
Chest
.
2002
;
122
(
5
):
1830
6
. .
12.
Sharp
C
,
Adamali
H
,
Millar
AB
.
Ambulatory and short-burst oxygen for interstitial lung disease
.
Cochrane Database Syst Rev
.
2016
;
7
:
CD011716
. .
13.
Cornet
AD
,
Kooter
AJ
,
Peters
MJ
,
Smulders
YM
.
The potential harm of oxygen therapy in medical emergencies
.
Crit Care
.
2013
;
17
(
2
):
313
. .
14.
Johannson
KA
,
Pendharkar
SR
,
Mathison
K
,
Fell
CD
,
Guenette
JA
,
Kalluri
M
, et al.
Supplemental oxygen in interstitial lung disease: an art in need of science
.
Ann Am Thorac Soc
.
2017
;
14
(
9
):
1373
7
. .
15.
Arizono
S
,
Furukawa
T
,
Taniguchi
H
,
Sakamoto
K
,
Kimura
T
,
Kataoka
K
, et al.
Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation
.
Respirology
.
2020
;
25
(
11
):
1152
. .
16.
Nishiyama
O
,
Miyajima
H
,
Fukai
Y
,
Yamazaki
R
,
Satoh
R
,
Yamagata
T
, et al.
Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia
.
Respir Med
.
2013
;
107
(
8
):
1241
6
. .
17.
Bell
EC
,
Cox
NS
,
Goh
N
,
Glaspole
I
,
Westall
GP
,
Watson
A
, et al.
Oxygen therapy for interstitial lung disease: a systematic review
.
Eur Respir Rev
.
2017
;
26
:
1
7
. .
18.
Dowman
LM
,
McDonald
CF
,
Bozinovski
S
,
Vlahos
R
,
Gillies
R
,
Pouniotis
D
, et al.
Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia
.
Respirology
.
2017
;
22
(
5
):
957
64
. .
19.
Vogiatzis
I
,
Louvaris
Z
,
Habazettl
H
,
Andrianopoulos
V
,
Wagner
H
,
Roussos
C
, et al.
Cerebral cortex oxygen delivery and exercise limitation in patients with COPD
.
Eur Respir J
.
2013
;
41
(
2
):
295
301
. .
20.
Hasler
ED
,
Saxer
S
,
Schneider
SR
,
Furian
M
,
Lichtblau
M
,
Schwarz
EI
, et al.
Effect of breathing oxygen-enriched air on exercise performance in patients with chronic obstructive pulmonary disease: randomized, placebo-controlled, cross-over trial
.
Respiration
.
2020
;
99
(
3
):
213
24
. .
21.
DU Plessis
JP
,
Fernandes
SE
,
Jamal
RA
,
Camp
PAT
,
Johannson
KE
,
Schaeffer
MI
, et al.
Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD
.
Respirology
.
2018
;
23
:
392
8
.
22.
McDonald
CF
.
Exercise desaturation and oxygen therapy in ILD and COPD: similarities, differences and therapeutic relevance
.
Respirology
.
2018
;
23
(
4
):
350
1
.
23.
Higashimoto
Y
,
Honda
N
,
Yamagata
T
,
Sano
A
,
Nishiyama
O
,
Sano
H
, et al.
Exertional dyspnoea and cortical oxygenation in patients with COPD
.
Eur Respir J
.
2015
;
46
(
6
):
1615
24
. .
24.
Malenfant
S
,
Brassard
P
,
Paquette
M
,
Le Blanc
O
,
Chouinard
A
,
Bonnet
S
, et al.
Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
.
Physiol Rep
.
2020
;
8
(
6
):
1
12
. .
25.
Raghu
G
,
Remy-Jardin
M
,
Myers
JL
,
Richeldi
L
,
Ryerson
CJ
,
Lederer
DJ
, et al.
Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline
.
Am J Respir Crit Care Med
.
2018
;
198
(
5
):
e44
68
. .
26.
Lama
VN
,
Flaherty
KR
,
Toews
GB
,
Colby
TV
,
Travis
WD
,
Long
Q
, et al.
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia
.
Am J Respir Crit Care Med
.
2003
;
168
(
9
):
1084
90
. .
27.
Jenkins
S
,
Čečins
N
.
Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease
.
Intern Med J
.
2011
;
41
(
5
):
416
22
. .
28.
American Thoracic Society; American College of Chest Physicians
.
ATS/ACCP statement on cardiopulmonary exercise testing
.
Am J Respir Crit Care Med
.
2003
;
167
(
2
):
211
77
.
29.
Neder
JA
,
Jones
PW
,
Nery
LE
,
Whipp
BJ
.
Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship
.
Am J Respir Crit Care Med
.
2000
;
162
(
2 Pt 1
):
497
504
. .
30.
Dennison
RA
,
Ward
RJ
,
Griffin
SJ
,
Usher-Smith
JA
.
Women’s views on lifestyle changes to reduce the risk of developing type 2 diabetes after gestational diabetes: a systematic review, qualitative synthesis and recommendations for practice
.
Diabet Med
.
2019
;
36
:
702
17
.
31.
Huppert
TJ
,
Diamond
SG
,
Franceschini
MA
,
Boas
DA
.
HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain
.
Appl Opt
.
2009
;
48
(
10
):
D280
98
. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf.
32.
Nielsen
HB
,
Boesen
M
,
Secher
NH
.
Near-infrared spectroscopy determined brain and muscle oxygenation during exercise with normal and resistive breathing
.
Acta Physiol Scand
.
2001
;
171
(
1
):
63
70
. .
33.
van Beekvelt
MC
,
van Engelen
BG
,
Wevers
RA
,
Colier
WN
.
In vivo quantitative near-infrared spectroscopy in skeletal muscle during incremental isometric handgrip exercise
.
Clin Physiol Funct Imaging
.
2002
;
22
(
3
):
210
7
. .
34.
Barstow
TJ
.
Understanding near infrared spectroscopy and its application to skeletal muscle research
.
J Appl Physiol
.
2019
;
126
(
5
):
1360
76
. .
35.
Dipla
K
,
Triantafyllou
A
,
Koletsos
N
,
Papadopoulos
S
,
Sachpekidis
V
,
Vrabas
IS
, et al.
Impaired muscle oxygenation and elevated exercise blood pressure in hypertensive patients: links with vascular stiffness
.
Hypertension
.
2017
;
70
(
2
):
444
51
. .
36.
Vainshelboim
B
,
Oliveira
J
,
Fox
BD
,
Kramer
MR
.
The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis
.
Respir Care
.
2016
;
61
(
8
):
1100
9
. .
37.
Ries
AL
.
Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg scale, and Visual Analog Scale
.
COPD
.
2005
;
2
(
1
):
105
10
.
38.
Dowman
LM
,
Mcdonald
CF
,
Hill
CJ
,
Lee
AL
,
Barker
K
,
Boote
C
, et al.
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
.
Thorax
.
2017
;
72
:
610
9
.
39.
Ogoh
S
,
Ainslie
PN
.
Cerebral blood flow during exercise: mechanisms of regulation
.
J Appl Physiol
.
2009
;
107
(
5
):
1370
80
. .
40.
Querido
JS
,
Sheel
AW
.
Regulation of cerebral blood flow during exercise
.
Sports Med
.
2007
;
37
(
9
):
765
82
. .
41.
Ide
K
,
Horn
A
,
Secher
NH
.
Cerebral metabolic response to submaximal exercise
.
J Appl Physiol
.
1999
;
87
(
5
):
1604
8
. .
42.
Kintiraki
E
,
Dipla
K
,
Triantafyllou
A
,
Koletsos
N
,
Grigoriadou
I
,
Poulakos
P
, et al.
Blunted cerebral oxygenation during exercise in women with gestational diabetes mellitus: associations with macrovascular function and cardiovascular risk factors
.
Metabolism
.
2018
;
83
:
25
30
. .
43.
Kim
YS
,
Seifert
T
,
Brassard
P
,
Rasmussen
P
,
Vaag
A
,
Nielsen
HB
, et al.
Impaired cerebral blood flow and oxygenation during exercise in type 2 diabetic patients
.
Physiol Rep
.
2015
;
3
(
6
):
1
13
. .
44.
Havakuk
O
,
King
KS
,
Grazette
L
,
Yoon
AJ
,
Fong
M
,
Bregman
N
, et al.
Heart failure-induced brain injury
.
J Am Coll Cardiol
.
2017
;
69
(
12
):
1609
16
. .
45.
Watson
NA
,
Beards
SC
,
Altaf
N
,
Kassner
A
,
Jackson
A
.
The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography
.
Eur J Anaesthesiol
.
2000
;
17
(
3
):
152
9
. .
46.
Ulrich
S
,
Hasler
ED
,
Müller-Mottet
S
,
Keusch
S
,
Furian
M
,
Latshang
TD
, et al.
Mechanisms of improved exercise performance under hyperoxia
.
Respiration
.
2017
;
93
(
2
):
90
8
. .
47.
Lucas
SJ
,
Ainslie
PN
,
Murrell
CJ
,
Thomas
KN
,
Franz
EA
,
Cotter
JD
.
Effect of age on exercise-induced alterations in cognitive executive function: relationship to cerebral perfusion
.
Exp Gerontol
.
2012
;
47
(
8
):
541
51
. .
48.
Hung
WW
,
Wisnivesky
JP
,
Siu
AL
,
Ross
JS
.
Cognitive decline among patients with chronic obstructive pulmonary disease
.
Am J Respir Crit Care Med
.
2009
;
180
(
2
):
134
7
. .
49.
Bors
M
,
Tomic
R
,
Perlman
DM
,
Kim
HJ
,
Whelan
TP
.
Cognitive function in idiopathic pulmonary fibrosis
.
Chron Respir Dis
.
2015
;
12
(
4
):
365
72
. .
50.
Fox
BD
,
Shostak
Y
,
Pertzov
B
,
Vainshelboim
B
,
Itzhakian
S
,
Terner
I
, et al.
IPF patients are limited by mechanical and not pulmonary-vascular factors: results of a derivation-validation cohort study
.
BMC Pulm Med
.
2019
;
19
(
1
):
1
8
. .
51.
Boutou
AK
,
Pitsiou
GG
,
Trigonis
I
,
Papakosta
D
,
Kontou
PK
,
Chavouzis
N
, et al.
Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension
.
Respirology
.
2011
;
16
(
3
):
451
8
. .
52.
Degani-Costa
LH
,
Levarge
B
,
Digumarthy
SR
,
Eisman
AS
,
Harris
RS
,
Lewis
GD
.
Pulmonary vascular response patterns during exercise in interstitial lung disease
.
Eur Respir J
.
2015
;
46
(
3
):
738
49
. .
53.
Louvaris
Z
,
Vogiatzis
I
,
Aliverti
A
,
Habazettl
H
,
Wagner
H
,
Wagner
P
, et al.
Blood flow does not redistribute from respiratory to leg muscles during exercise breathing heliox or oxygen in COPD
.
J Appl Physiol
.
2014
;
117
(
3
):
267
76
. .
54.
Bartels
MN
,
Gonzalez
JM
,
Kim
W
,
De Meersman
RE
.
Oxygen supplementation and cardiac-autonomic modulation in COPD
.
Chest
.
2000
;
118
(
3
):
691
6
. .
55.
Nishiyama
O
,
Taniguchi
H
,
Kondoh
Y
,
Kimura
T
,
Ogawa
T
,
Watanabe
F
, et al.
Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis
.
Chest
.
2005
;
127
:
2028
33
. .
56.
Mendoza
L
,
Gogali
A
,
Shrikrishna
D
,
Cavada
G
,
Kemp
SV
,
Natanek
SA
, et al.
Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia
.
Respirology
.
2014
;
19
(
1
):
138
43
. .
57.
Wahr
JA
,
Tremper
KK
,
Samra
S
,
Delpy
DT
.
Near-infrared spectroscopy: theory and applications
.
J Cardiothorac Vasc Anesth
.
1996
;
10
(
3
):
406
18
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.